Medication Information
Please read the information linked below. It contains important warnings from the FDA in relation to medications you may be prescribed. If you have any questions, please speak to your provider or other licensed healthcare professional.
Please note: Many medications prescribed via UrWay Health are compounded medications. These are prepared with utmost care in licensed pharmacies, and while their efficacy and safety profiles may not be directly comparable to commercial drugs, they are tailored to meet individual patient needs. Talk to your provider about the specific risks and benefits that may come with the use of a compounded medication. The following list of safety data is provided solely for convenience and should not be relied upon in relation to the safety and efficacy profile of any compounded medications.
Medical Weight Management Medications
Semaglutide (Active Pharmaceutical Ingredient in Wegovy®)
Please See: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf
Compound Semaglutide - Important GLP-1 Safety Information
https://urwayhealth.com/page/Semaglutide-Important-GLP-1-Safety-Information
Tirzepatide (Active Pharmaceutical Ingredient in Mounjaro®)
Please see: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf
Compound Tirzepatide Important GLP-1 Safety Information
https://urwayhealth.com/page/Tirzepatide-Important-GLP-1-Safety-Information
Hormone Replacement Therapy Medications
UrWay Health recognizes the importance of Hormone Replacement Therapy (HRT) Medications in addressing specific medical needs. HRT Medications, such as Testosterone Cypionate (Active Pharmaceutical Ingredient in Depo® -Testosterone), may be prescribed to patients for hormone-related conditions. It is crucial for patients to understand the purpose and significance of these medications in their treatment plan. Therefore, UrWay Health encourages patients to review the following information provided by the FDA:
Testosterone Cypionate (Active Pharmaceutical Ingredient in Depo® -Testosterone)
Please See: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/085635s040lbl.pdf
